Efficacy of diclofenac in the prevention of post-ERCP pancreatitis in predominantly high-risk patients: a randomized double-blind prospective trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy of diclofenac in the prevention of post-ERCP pancreatitis in predominantly high-risk patients: a randomized double-blind prospective trial

Published:2007-12 Issue:6 Volume:66 Page:1126-1132
ISSN:0016-5107
Container-title:Gastrointestinal Endoscopy
language:en
Short-container-title:Gastrointestinal Endoscopy

Author:

Cheon Young Koog,Cho Kwang Bum,Watkins James L.,McHenry Lee,Fogel Evan L.,Sherman Stuart,Schmidt Suzette,Lazzell-Pannell Laura,Lehman Glen A.

Publisher

Elsevier BV

Subject

Gastroenterology,Radiology, Nuclear Medicine and imaging

Reference28 articles.

1. Risk factors for post-ERCP pancreatitis: a prospective, multicenter study;Freeman;Gastrointest Endosc,2001

2. Pancreatic stenting prevents pancreatitis after biliary sphincterotomy in patients with sphincter of Oddi dysfunction;Tarnasky;Gastroenterology,1998

3. Does prophylactic pancreatic stent placement reduce the risk of post-ERCP acute pancreatitis? A meta-analysis of controlled trials;Singh;Gastrointest Endosc,2004

4. Pancreatic stenting prevents pancreatitis after biliary sphincterotomy in patients with sphincter of Oddi dysfunction;Tarnasky;Gastroenterology,1998

5. Does a pancreatic duct stent prevent post-ERCP pancreatitis? A prospective randomized study;Fazel;Gastrointest Endosc,2003

Cited by 97 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Updates in Post–Endoscopic Retrograde Cholangiopancreatography Pancreatitis;Gastroenterology Clinics of North America;2024-09

2. Effectiveness of the pharmacological therapy to prevent post ERCP acute pancreatitis: a network meta-analysis;Expert Review of Gastroenterology & Hepatology;2024-05-03

3. Intravenous Hemin, a potential heme oxygenase-1 activator, does not protect from post-ERCP acute pancreatitis in humans: Results of a randomized multicentric multinational placebo-controlled trial;Pancreatology;2024-05

4. ERCP後膵炎ガイドライン2023;Suizo;2024-04-30

5. NSAIDs do not reduce severity among post-ERCP pancreatitis patients;Pancreatology;2024-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3